These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 19631647)

  • 1. Coordinated control of a designed trans-acting ligase ribozyme by a loop-receptor interaction.
    Matsumura S; Ohmori R; Saito H; Ikawa Y; Inoue T
    FEBS Lett; 2009 Sep; 583(17):2819-26. PubMed ID: 19631647
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural and biochemical characterization of DSL ribozyme.
    Horie S; Ikawa Y; Inoue T
    Biochem Biophys Res Commun; 2006 Jan; 339(1):115-21. PubMed ID: 16298344
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro selection of an allosteric ribozyme that transduces analytes to amplicons.
    Robertson MP; Ellington AD
    Nat Biotechnol; 1999 Jan; 17(1):62-6. PubMed ID: 9920271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rational optimization of the DSL ligase ribozyme with GNRA/receptor interacting modules.
    Ishikawa J; Matsumura S; Jaeger L; Inoue T; Furuta H; Ikawa Y
    Arch Biochem Biophys; 2009 Oct; 490(2):163-70. PubMed ID: 19728985
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cis and trans reactions of hairpin ribozymes derived from the negative strand of arabis mosaic virus satellite RNA.
    Tomita R; Morikawa Y; Hisamatsu S; Suzuki-Fujita K; Tanaka T; Sonoki S; Kikuchi Y
    Nucleic Acids Symp Ser; 1995; (34):117-8. PubMed ID: 8841580
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tertiary structure stabilization promotes hairpin ribozyme ligation.
    Fedor MJ
    Biochemistry; 1999 Aug; 38(34):11040-50. PubMed ID: 10460159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro selection of a 5'-purine nucleotide transferase ribozyme.
    Kang TJ; Suga H
    Nucleic Acids Symp Ser (Oxf); 2007; (51):379-80. PubMed ID: 18029745
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A ligase ribozyme obtained from a structured pool.
    Yoshioka W; Ikawa Y; Jaeger L; Inoue T
    Nucleic Acids Symp Ser (Oxf); 2004; (48):209-10. PubMed ID: 17150552
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficient, pH-dependent RNA ligation by the VS ribozyme in trans.
    McLeod AC; Lilley DM
    Biochemistry; 2004 Feb; 43(4):1118-25. PubMed ID: 14744158
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative single-turnover kinetic analyses of trans-cleaving hammerhead ribozymes with naturally derived non-conserved sequence motifs.
    Weinberg MS; Rossi JJ
    FEBS Lett; 2005 Mar; 579(7):1619-24. PubMed ID: 15757651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-range impact of peripheral joining elements on structure and function of the hepatitis delta virus ribozyme.
    Tinsley RA; Walter NG
    Biol Chem; 2007 Jul; 388(7):705-15. PubMed ID: 17570823
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Artificial ligase ribozymes isolated by a "design and selection" strategy.
    Matsumura S; Ikawa Y
    Methods Mol Biol; 2015; 1316():113-25. PubMed ID: 25967057
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Construction of an artificial ribozyme which ligates an RNA fragment activated by nicotinamide mononucleotide.
    Fujita Y; Furuta H; Ikawa Y
    Nucleic Acids Symp Ser (Oxf); 2006; (50):231-2. PubMed ID: 17150902
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Concerted effects of two activator modules on the group I ribozyme reaction.
    Ikawa Y; Shiohara T; Ohuchi S; Inoue T
    J Biochem; 2009 Apr; 145(4):429-35. PubMed ID: 19122204
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selection of a novel class of RNA-RNA interaction motifs based on the ligase ribozyme with defined modular architecture.
    Ohuchi SP; Ikawa Y; Nakamura Y
    Nucleic Acids Res; 2008 Jun; 36(11):3600-7. PubMed ID: 18460545
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Using RNAFOLD to predict the activity of small catalytic RNAs.
    Denman RB
    Biotechniques; 1993 Dec; 15(6):1090-5. PubMed ID: 8292343
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Interaction between RNA molecules of a two-componet trans-analog of antigenomic HDV-ribozyme].
    Alekseenkova VA; Belianko TI; Lukin MA; Savochkina LP; Bibilashvili RSh
    Mol Biol (Mosk); 2006; 40(1):90-9. PubMed ID: 16523696
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The secondary structure and sequence optimization of an RNA ligase ribozyme.
    Ekland EH; Bartel DP
    Nucleic Acids Res; 1995 Aug; 23(16):3231-8. PubMed ID: 7667099
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systematic minimization of RNA ligase ribozyme through large-scale design-synthesis-sequence cycles.
    Nomura Y; Yokobayashi Y
    Nucleic Acids Res; 2019 Sep; 47(17):8950-8960. PubMed ID: 31504757
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evolutionary optimization of a modular ligase ribozyme: a small catalytic unit and a hairpin motif masking an element that could form an inactive structure.
    Fujita Y; Furuta H; Ikawa Y
    Nucleic Acids Res; 2010 Jun; 38(10):3328-39. PubMed ID: 20110262
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.